David Altshuler, EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,226 shares at $480.00 ($3.5M) on 2025-02-27, disclosed to the SEC on 2025-02-28.
Scheduled sale ($3.5M) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $479.61 | 5,954 | $2.9M | 82.4% |
| 2 | $480.00 | 1,272 | $611K | 17.6% |
| Total | $479.68 avg | 7,226 | $3.5M | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-03-05 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-02-26 | $816K | — | Filing → |